18 июня 2025 г.

ОБ ЭТОМ ЭПИЗОДЕ

Exploring the Endocannabinoid System: A New Era in Therapy

EP3 - In this special edition episode, Releaf COO Graham Woodward sits down with cannabinoid pharmacologist Professor Saoirse O’Sullivan to explore whether our current approach to cannabis-based treatment is truly evidence-led or built on outdated myths.

From the science behind THC and CBD to the truth about the entourage effect, this episode challenges assumptions and asks what it takes to get cannabis medicine right.

Spotify Video Chapters:

00:00 Beyond The Script with Saoirse O’Sullivan

01:00 Understanding the Endocannabinoid System

03:07 Tailoring Treatments with Cannabinoid Science

04:35 Exploring Minor Phytocannabinoids

07:10 Real-World Evidence and Clinical Trials

09:18 Pharmaceutical Insights and Future Directions

17:02 The Entourage Effect

19:23 Future of Cannabinoid Treatments

23:33 Conclusion and Final Thoughts

Медицина

Естественные науки

Здоровье и фитнес

Медицина

Ciencias de la vida

Бизнес

английский

США

ИспользуйтеAPI, чтобы загрузить этот эпизод вJSON.

В ЭТОМ ЭПИЗОДЕ

graham woodward

Изменить эти теги

РАСШИФРОВКА 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

ПОИСК ПРОШЛЫХ ЭПИЗОДОВ

Искать прошлые эпизоды Beyond The Script.

Вставьте эту панель поиска на свой сайт

ДРУГИЕ ЭПИЗОДЫ В ЭТОМ ПОДКАсте

Unlocking the Medical Cannabis Market: Revolutionising Access and Innovation

20 июня 2025 г.

EP4 - Tim Kirby, CEO of Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals discuss strategies for expanding the medical cannabis market in the UK. They highlight the challenges in the current market, such as patient accessibility and supply chain issues, emph…

00:37:24

СОХРАНИТЬ

Клип

Power, Politics and the Future of UK Medical Cannabis

11 июня 2025 г.

EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation. Key topics include: - Why the UK's medical…

00:37:57

СОХРАНИТЬ

Клип

The UK's Largest Ever Medical Cannabis Deal

9 июня 2025 г.

EP1 - CEOs Tim Kirby of Releaf and James Duckenfield of Glass Pharm sat down to discuss the ever-evolving UK medical cannabis sector. In 2024, we joined forces with Glass Pharms in the UK's largest ever medical cannabis deal, providing Releaf patients with a consistent, high-quality supply of…

00:52:29

СОХРАНИТЬ

Клип

From Anecdote to Evidence: Using Data for Advanced Access | Releaf & Dr Anne Katrin Schlag

10 июля 2025 г.

EP5 - Join COO of Releaf, Graham Woodward, and Dr Anne Katrin Schlag, Head of Research at Drug Science, as they explore how the UK can move from anecdotal patient stories to real-world evidence, and why this shift is vital for expanding safe, trusted access to cannabis-based medicines. Let's rethin…

00:26:40

СОХРАНИТЬ

Клип

Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из Releaf, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.